Helen Sabzevari - Mar 24, 2023 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
President and CEO, Director
Signature
/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Stock symbol
PGEN
Transactions as of
Mar 24, 2023
Transactions value $
$0
Form type
4
Date filed
3/28/2023, 09:08 PM
Previous filing
Jan 30, 2023
Next filing
May 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Options Exercise +283K +30.2% 1.22M Mar 24, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Award $0 +850K $0.00 850K Mar 24, 2023 Common Stock 850K Direct F1, F2
transaction PGEN Restricted Stock Units Options Exercise $0 -283K -33.33% $0.00 566K Mar 24, 2023 Common Stock 283K Direct F1, F3
transaction PGEN Option to Purchase Common Stock (Right to Buy) Award $0 +370K $0.00 370K Mar 24, 2023 Common Stock 370K $0.96 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F2 1/3 of the RSUs vested immediately upon the grant date, and the remaining RSUs vest in four equal installments on each of August 2, 2023, August 9, 2023, August 16, 2023 and August 23, 2023.
F3 Represents 1/3 of the RSUs granted on March 24, 2023 that vested immediately.